GDNF promotes cancer progression by binding to GDNF family receptors α1-3 and RET proto-oncogene (RET), which initiate the downstream activation of several signaling pathways, including RAS/ERK, MAPK, JNK, and PI3-K/Akt [105,106]. Here, AKT1 is linked to cancer.